Showing 1 - 8 of 8
Persistent link: https://www.econbiz.de/10013433326
Conflicting trends confound the pharmaceutical industry. The productivity of pharmaceutical innovation has declined in recent years. At the same time, the cohort of large companies who are the leading engines of pharmaceutical R&D has become increasingly concentrated. The concurrent presence of...
Persistent link: https://www.econbiz.de/10013096412
This paper offers a critique of a recent paper on vertical restraints by four Federal Trade Commission staff members. The FTC staff based much of their analysis on a survey of 22 previously published case studies. We argue that the sample of 22 is biased toward cases in which vertical restraints...
Persistent link: https://www.econbiz.de/10012725193
Persistent link: https://www.econbiz.de/10010538266
Persistent link: https://www.econbiz.de/10010843441
There is no more important issue in the economics of the family than the impact of parents on the behavior of their children. By providing rewards and imposing constraints, parents seek to affect their children’s behavior. The explanation of these actions is that the child’s conduct directly...
Persistent link: https://www.econbiz.de/10005168945
Persistent link: https://www.econbiz.de/10005478576
The U.S. pharmaceutical industry has experienced in recent years two dramatic changes: stagnation in the growth of new molecular entities approved for marketing, and a wave of mergers linking inter alia some of the largest companies. This paper explores possible links between these two phenomena...
Persistent link: https://www.econbiz.de/10011139840